{
    "id": "fe9562e3-8bb4-46e9-b8f3-9192fabad7a2",
    "indications": "litfulo kinase inhibitor indicated treatment severe alopecia areata adults adolescents 12 years older . limitations : recommended combination jak inhibitors , biologic immunomodulators , cyclosporine potent immunosuppressants .",
    "contraindications": "• recommended testing , evaluations immunizations prior litfulo initiation , full prescribing information . ( 2.1 ) • recommended 50 mg orally daily . ( 2.2 ) • interruption certain , full prescribing information . ( 2.4 )",
    "warningsAndPrecautions": "litfulo capsules packaged child-resistant , white , high-density polyethylene ( hdpe ) bottles polypropylene ( pp ) cap foil heat induction seal liner . bottles contain 1g desiccant high-density polyethylene ( hdpe ) canister . eat desiccant . form strength description bottle size ( number capsules ) ndc number capsules 50 mg ritlecitinib size 3 , opaque capsules yellow body blue cap . body printed “ rcb 50 ” cap printed “ pfizer ” black . 28 count bottle 0069-0334-28",
    "adverseReactions": "litfulo contraindicated patients known hypersensitivity ritlecitinib excipients [ ( 5.6 ) ] .",
    "ingredients": [
        {
            "name": "RITLECITINIB TOSYLATE",
            "code": "EAG4T1459K"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "organization": "Pfizer Laboratories Div Pfizer Inc",
    "name": "Litfulo",
    "effectiveTime": "20250522",
    "indications_original": "LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. \n                  \n                     Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.",
    "contraindications_original": "• For recommended testing, evaluations and immunizations prior to LITFULO initiation, see Full Prescribing Information. ( 2.1 ) • Recommended dosage is 50 mg orally once daily. ( 2.2 ) • For dosage interruption for certain adverse reactions, see Full Prescribing Information. ( 2.4 )",
    "warningsAndPrecautions_original": "LITFULO capsules are packaged in child-resistant, white, high-density polyethylene (HDPE) bottles with polypropylene (PP) cap with a foil heat induction seal liner. The bottles contain 1g of desiccant in a high-density polyethylene (HDPE) canister. Do not eat the desiccant.\n                  \n                     \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Dosage Form\n                              \n                           \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 Description\n                              \n                           \n                           \n                              \n                                 Bottle Size\n                              \n                              \n                                 (number of capsules)\n                              \n                           \n                           \n                              \n                                 NDC Number\n                              \n                           \n                        \n                        \n                           \n                              Capsules\n                           \n                           \n                              50 mg of ritlecitinib\n                           \n                           \n                              Size 3, opaque capsules with yellow body and blue cap. The body is printed with “RCB 50” and the cap is printed with “Pfizer” in black.\n                           \n                           \n                              28 count bottle\n                           \n                           \n                              0069-0334-28",
    "adverseReactions_original": "LITFULO is contraindicated in patients with known hypersensitivity to ritlecitinib or any of its excipients [see Warnings and Precautions (5.6)]."
}